FANJ
BEAT

Financial Architects (New Jersey)’s BioTelemetry, Inc. BEAT Stock Holding History

Financial Architects (New Jersey)’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$13K – 1586
2019
Q1 		$13K Sell
200
-300
-60% -$20.6K ﹤0.01% 1037
2018
Q4 		$30K Buy
+500
New +$30K 0.01% 699

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Architects (New Jersey)'s BEAT Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 200 shares — an estimated $13K sold.

Financial Architects (New Jersey) first reported a position in BEAT in Q4 2018 and held it in 2 quarters. The position peaked at $30K in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 200 BioTelemetry, Inc. shares in Q2 2019, an estimated $13K.
  • Financial Architects (New Jersey) first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 2 quarters.
  • Financial Architects (New Jersey)'s BioTelemetry, Inc. position peaked at $30K in Q4 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.